EstablishINg the best STEp-up treatments for children with uncontrolled asthma despite INhaled corticosteroids (EINSTEIN): protocol for a systematic review, network meta-analysis and cost-effectiveness analysis using individual participant data (IPD)
Open Access
- 5 February 2021
- Vol. 11 (2), e040528
- https://doi.org/10.1136/bmjopen-2020-040528
Abstract
Introduction Asthma affects millions of children worldwide—1.1 million children in the UK. Asthma symptoms cannot be cured but can be controlled with low-dose inhaled corticosteroids (ICSs) in the majority of individuals. Treatment with a low-dose ICS, however, fails to control asthma symptoms in around 10%–15% of children and this places the individual at increased risk for an asthma attack. At present, there is no clear preferred treatment option for a child whose asthma is not controlled by low-dose ICS and international guidelines currently recommend at least three treatment options. Herein, we propose a systematic review and individual participant data network meta-analysis (IPD-NMA) aiming to synthesise all available published and unpublished evidence from randomised controlled trials (RCTs) to establish the clinical effectiveness of pharmacological treatments in children and adolescents with uncontrolled asthma on ICS and help to make evidence-informed treatment choices. This will be used to parameterise a Markov-based economic model to assess the cost-effectiveness of alternative treatment options in order to inform decisions in the context of drug formularies and clinical guidelines. Methods and analysis We will search in MEDLINE, the Cochrane Library, the Cochrane Central Register of Controlled Trials (CENTRAL), Embase, NICE Technology Appraisals and the National Institute for Health Research (NIHR) Health Technology Assessment series for RCTs of interventions in patients with uncontrolled asthma on ICS. All studies where children and adolescents were eligible for inclusion will be considered, and authors or sponsors will be contacted to request IPD on patients aged Ethics and dissemination The Committee on Research Ethics, University of Liverpool, has confirmed that ethics review is not required. The dissemination plan consists of publishing the results in an open-access medical journal, a plain-language summary available for parents and children, dissemination via local, national and international meetings and conferences and the press offices of our Higher Education Institutions (HEIs). A synopsis of results will be disseminated to NICE and British Thoracic Society/Scottish Intercollegiate Guidelines Network (SIGN) as highly relevant to future clinical guideline updates. PROSPERO registration number CRD42019127599.Funding Information
- NIHR HTA (16/110/16)
This publication has 45 references indexed in Scilit:
- Evidence Synthesis for Decision Making 6Medical Decision Making, 2013
- A systematic review with attempted network meta-analysis of asthma therapy recommended for five to eighteen year olds in GINA steps three and fourBMC Pulmonary Medicine, 2012
- Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young peopleTrials, 2012
- Pediatric Asthma Caregiver’s Quality of Life Questionnaire is a useful tool for monitoring asthma in childrenQuality of Life Research, 2011
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Factors Associated with the Development of Severe Asthma Exacerbations in ChildrenJournal of Asthma, 2011
- Hospitalizations for Asthma in Children Are Linked to Undertreatment and Insufficient Asthma EducationJournal of Asthma, 2011
- Asthma Control Questionnaire in children: validation, measurement properties, interpretationEuropean Respiratory Journal, 2010
- Step-up Therapy for Children with Uncontrolled Asthma Receiving Inhaled CorticosteroidsThe New England Journal of Medicine, 2010
- Using Value of Information Analysis to Prioritise Health ResearchPharmacoEconomics, 2006